Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Gossamer Bio said its board approved amended bylaws effective Sept. 3, 2026. The company plans to present on seralutinib at the Cantor Global Healthcare Conference in New York on Sept. 9, 2026, with follow-up meetings planned.
Gossamer Bio, Inc. says its board approved an amendment and restatement of its bylaws, effective Sept 3, 2026.